Lupin gets USFDA nod for Kapvay tablets
Lupin announced that it has received final approval for its Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg from the United States Food and Drug Administration (FDA) to market a generic version of Concordia Pharmaceuticals Inc.’s Kapvay Extended-Release Tablets 0.1 mg.
Lupin’s Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg is the AB rated generic equivalent of Concordia Pharmaceuticals Inc.’s Kapvay Extended-Release Tablets 0.1 mg. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications.
Jubilant Foodworks Q2FY18 standalone net profit rises 124.5% yoy to Rs.48.5 crore
Jubilant Foodworks consolidated revenue for the quarter came in at Rs. 726.6 crore, registering 9.2% yoy increase.
EBITDA for the quarter rose by 59.4% yoy to Rs. 102 crore with a corresponding margin expansion of 442 bps. EBITDA margin for the quarter stood at 14%. This margin expansion was aided by decrease in other expenses by 1.5% The PAT for the quarter came in at Rs. 48.5 crore, yoy increase of 124.5%. This was due to decrease in depreciation expense by 11.1%.
Castrol India to consider bonus issue on Nov 7
Castrol India Ltd is currently trading at Rs 402.65, up by Rs 17 or 4.41% from its previous closing of Rs 385.65 on the BSE as the company's board will meet on Nov 7 to consider issuing bonus shares.
The scrip opened at Rs 389.8 and has touched a high and low of Rs 412 and Rs 386.25 respectively. The stock is currently trading above its 200 DMA.Castrol India is an India-based company engaged in providing coke and refined petroleum products. The company generated 80% of revenues from automotive segment, 11% from non-automotive and the rest from trades in CY16.
Engineers India stock zooms 8% after Q2 FY18 PAT rises 27%
Engineers India stock zoomed 8% after the company’s PAT increased by 27% to Rs 119 crore in Q2 FY18.The company’s standalone revenue for the quarter came in at Rs 429 crore, registering 26.6% yoy increase.This was primarily driven by revenue growth in Consultancy & Engineering projects and Turn Key projects by 21.1% and 50.2%
Engineers India Ltd is currently trading at Rs 170.65, up by Rs 12.7 or 8.04% from its previous closing of Rs 157.95 on the BSE. The scrip opened at Rs 160 and has touched a high and low of Rs 173.3 and Rs 160 respectively.
Polaris board to consider Delisting of Equity Shares
Polaris Consulting & Services Ltd informed through a filing with BSE that its promoter Virtusa Consulting Services Private Limited (VCS) along with the members of the Promoter Group intends to voluntarily delist the equity shares of the company currently listed on the BSE Limited, the National Stock Exchange of India Limited and the Metropolitan Stock Exchange of India Limited.
Presently, the Company’s public shareholders hold 26,172,715 equity shares of Rs 5 each representing 25.60% of the equity shares of the company.
Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
